These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18656518)

  • 1. The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.
    Thompson JM; Whitmore AC; Staats HF; Johnston R
    Vaccine; 2008 Sep; 26(39):4998-5003. PubMed ID: 18656518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal and systemic adjuvant activity of alphavirus replicon particles.
    Thompson JM; Whitmore AC; Konopka JL; Collier ML; Richmond EM; Davis NL; Staats HF; Johnston RE
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3722-7. PubMed ID: 16505353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.
    Thompson JM; Whitmore AC; Staats HF; Johnston RE
    Vaccine; 2008 Aug; 26(33):4267-75. PubMed ID: 18582997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques.
    Carroll TD; Matzinger SR; Barro M; Fritts L; McChesney MB; Miller CJ; Johnston RE
    Vaccine; 2011 Jan; 29(5):931-40. PubMed ID: 21111777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
    Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
    J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
    Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
    J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
    Hubby B; Talarico T; Maughan M; Reap EA; Berglund P; Kamrud KI; Copp L; Lewis W; Cecil C; Norberg P; Wagner J; Watson A; Negri S; Burnett BK; Graham A; Smith JF; Chulay JD
    Vaccine; 2007 Nov; 25(48):8180-9. PubMed ID: 17961878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
    Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
    J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses.
    Schultz-Cherry S; Dybing JK; Davis NL; Williamson C; Suarez DL; Johnston R; Perdue ML
    Virology; 2000 Dec; 278(1):55-9. PubMed ID: 11112481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.
    Cecil C; West A; Collier M; Jurgens C; Madden V; Whitmore A; Johnston R; Moore DT; Swanstrom R; Davis NL
    Virology; 2007 Jun; 362(2):362-73. PubMed ID: 17275057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
    White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
    J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
    Ye L; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
    Agnihothram S; Menachery VD; Yount BL; Lindesmith LC; Scobey T; Whitmore A; Schäfer A; Heise MT; Baric RS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.
    Tonkin DR; Whitmore A; Johnston RE; Barro M
    Vaccine; 2012 Jun; 30(30):4532-42. PubMed ID: 22531556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
    Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
    J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.